Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in Patients With LA-NPC
NCT04015661
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
92
Enrollment
OTHER
Sponsor class
Conditions
Nasopharyngeal Carcinoma
Interventions
DRUG:
Nab-paclitaxel
Sponsor
Fuzhou General Hospital